GetPortalImpactFactorByIdResp(projectId=1, id=b2851603, cover=https://img.medsci.cn/images/journal/cover/2021/tqE_202109271314442370.jpg, fullname=CNS DRUGS, abbr=CNS DRUGS, pyear=1994, frequence=Monthly, articleNumbers=1069, citedSelf2015=2.4, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均1.5月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1172-7047, greenSci=https://www.greensci.net/search?kw=1172-7047, scijournal=https://www.scijournal.org/impact-factor-of-CNS-DRUGS.shtml, medsciHotlightString=null, medsciHotlightRealtime=2.957, medsciHotlight=2.46, medsciHotlight5year=3.74137, citescore=12.0, hIndex=108, impactFactor=6.0, orgnization=Adis International Ltd, orgnizationUrl=http://www.adisonline.info/, country=United Kingdom, countryCn=英国, isOa=0, isOaString=否, sciScie=Science Citation Index|Science Citation Index Expanded|Current Contents - Clinical Medicine|Current Contents - Life Sciences|BIOSIS Previews|BIOSIS Reviews Reports And Meetings, bigclassCas=医学 2区, smallclassCas=医学 2 区, website=https://link.springer.com/journal/40263, websiteHits=5831, guideForAuthor=https://link.springer.com/journal/40263/submission-guidelines, guideForAuthorHits=23, submitWebsite=https://www.editorialmanager.com/cnsa/, submitWebsiteHits=1797, content=<p>Published by Adis International Limited (now part of Wolters Kluwer Health). ISSN: 1172-7047.<br /><br />CNS Drugs is your source for essential information about the treatment of psychiatric and neurological disorders. The journal takes a bench to bedside approach, covering topics from basic pharmacology and disease pathology, to drugs in development and guidelines for clinical practice. CNS Drugs' structured program of peer reviewed articles written by international experts provides essential reading each month for pharmaceutical industry clinical researchers, clinical pharmacologists, drug information pharmacists and specialist clinicians in the CNS area.</p> <p style="color: #222222;"><em><span>CNS Drugs</span></em><span>为研究人员和医疗保健专业人士提供了有关用于治疗神经和精神疾病的药物疗法的最重要方面的重要信息。</span></p> <p style="color: #222222;"><span>该期刊通过评论和原创研究文章的计划，讨论了与这些疾病的药物治疗有关的主要问题，包括主要类别药物的药理学、功效和副作用；新开发药物和药物类别的信息；对神经和精神疾病病因的最新研究的治疗意义；以及特定临床情况的实际管理。</span></p> <p style="color: #222222;"><span>作为一本混合型期刊，</span><em><span>《CNS Drugs》</span></em><span>不向采用传统订阅式出版方式的作者收取出版费用，但如果作者愿意或其资助者要求，则提供以开放获取方式出版已接受文章的选项</span></p> <p style="color: #222222;"> </p>, totalCites=6418, brief=CNS DRUGS杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=精神病学" >精神病学</a></strong>”子行业的优秀级杂志, articleType=本刊接收类型不明, medsciHeat=黑红, medsciComment=CNS DRUGS在该细分领域可能是一流杂志，可能是创刊时间短或不是热门学科，整体来说，国内学者关注度仍然不够。对于投稿而言，建议多向"&abbr&"投稿，当然期刊也应该加强品牌宣传。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='//m.sandwebs.com/sci/submit.do?id=b2851603'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=3283, tagName=神经疾病, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2017, citescore=4.49), GetImpactFactorCiteScoreListResponse(year=2018, citescore=4.64), GetImpactFactorCiteScoreListResponse(year=2019, citescore=7.9), GetImpactFactorCiteScoreListResponse(year=2020, citescore=8.6), GetImpactFactorCiteScoreListResponse(year=2023, citescore=12.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=3.604), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=2.69), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=2.677), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=2.441), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=2.957)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Pharmacology (medical) , rank=9/232), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Psychiatry and Mental Health , rank=28/494), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Neurology (clinical) , rank=29/336)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=CLINICAL NEUROLOGY, rank=Q1), GetImpactFactorCiteScoreGradeResponse(smallClass=PHARMACOLOGY & PHARMACY, rank=Q1), GetImpactFactorCiteScoreGradeResponse(smallClass=PSYCHIATRY, rank=Q1)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1172-7047[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=CNS DRUGS[ta], article_number=95, article_number_cn=7, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)